Patents by Inventor Moo K. Park

Moo K. Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
    Patent number: 5011852
    Abstract: A one phase, liquid composition for oral administration comprises a NSAID such as an indoleacetic acid derivative or a pyrroleacetic acid derivative plus a di- or triglyceride of a medium chain fatty acid edible oil which has the characteristics of a pharmaceutical solvent carrier as known to those skilled in the art. Other pharmaceutical additives may be optionally added. An additional stipulation is that ethanol or other monohydric alcohol solvents should not be present.
    Type: Grant
    Filed: March 6, 1990
    Date of Patent: April 30, 1991
    Assignee: Applied Analytical Industries, Inc.
    Inventors: Moo K. Park, Henry C. Caldwell
  • Method for preparing high potency sucralfate
    Patent number: 4990610
    Abstract: Sucralfate is prepared in good yields and in newly useful form first by reacting sucrose with chlorosulfonic acid in 2-picoline. The amonium salt is then formed and reacted with aluminum chlorohydrate in specific sequence and alcoholic solvent. The two distinct products have unexpected pharmaceutical and physical characteristics. The oral liquid suspensions also must be critically formulated.
    Type: Grant
    Filed: December 16, 1988
    Date of Patent: February 5, 1991
    Assignee: Applied Analytical Industries, Inc.
    Inventors: Nick V. Lazaridis, Moo K. Park, Yousry Sayed
  • Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
    Patent number: 4918103
    Abstract: A pharmaceutically elegant, one phase, liquid composition for oral administration comprises a NSAID such as ibuprofen plus a di- or triglyceride of a medium chain fatty acid edible oil which has the characteristics of a pharmaceutical solvent carrier as known to those skilled in the art. Other pharmaceutical additives may be optionally added. An additional stipulation is that ethanol or other monohydric alcohol solvents should not be present.
    Type: Grant
    Filed: July 25, 1988
    Date of Patent: April 17, 1990
    Assignee: Formulations Development Labs
    Inventors: Moo K. Park, Henry C. Caldwell
  • Oral liquid pharmaceutical compositions of sulindac
    Patent number: 4880835
    Abstract: Pharmaceutically elegant oral liquid compositions of sulindac are prepared using calcium sulindac in a vehicle comprising a glycol, a polyol, optional ethanol and pharmaceutical additives.
    Type: Grant
    Filed: November 3, 1988
    Date of Patent: November 14, 1989
    Assignee: Formulations Development Labs, Inc.
    Inventor: Moo K. Park